Chris Williamson turns to peptide sourcing, a live issue as unregulated sellers and fake pens draw attention from regulators.
Recap by typeshit. Video by @chriswillx on TikTok.
Dr Bajekal flags that people on Mounjaro, semaglutide or Wegovy should talk it through with their doctor ahead of an operation.
The Form 483 cites microbial growth in a clean hood, reversed cleanroom air pressure and active ingredients marked for research use only. Check which pharmacy filled your vial.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
A hype-heavy explainer on retatrutide, the Lilly drug that targets three hormone pathways at once. It doesn't add anything new on trials or approval timing.
Gallup puts US adult GLP-1 use at 11%. PepsiCo and Hershey shares are down over the past year, though Hershey's breath mint sales are growing.
Loading…